First Asymmetric Synthesis of a Virola sebifera Lignan
FULL PAPER
CHCl3). 1H NMR (300 MHz, CDCl3) mixture of epimers: δ = 1.53/
1.57 (s, 3 H, CCH3), 1.58/1.57 (s, 3 H, CCH3), 2.29/2.41 (s, 3 H,
NCH3), 2.86/2,89 (td, J = 3.3, 1.4 Hz, 1 H, NCHCH2), 4.20/4.32
(CHCH3), 19.3 (CCH3), 28.8 (CCH3), 35.4 (NCH3), 36.5
(CHCH3), 42.5 (COCH2), 54.4 (NCH), 58.8 (OCH2CH), 73.1
(CCN), 76.0 (PhCH), 99.4 (OCCH3), 101.5 (OCH2O), 101.8
(dd, J = 13.0, 3.3 Hz, 1 H, OCHHCH), 4.40/5.50 (s, 1 H, CHCN), (OCH2O), 107.7, 107.8, 108.6 (Ar-CH), 121.1 (CCN), 121.8, 124.3
4.53/4.60 (dd, J = 13.0, 1.4 Hz, OCHHCH), 5.25/5.28 (d, J =
3.3 Hz, 1 H, OCHPh), 5.87–5,95 (m, 2 H, OCH2O and 1 H,
CHarom), 6.47 (m, 1 H, CHarom), 6.55–6.61 (m, 1 H, CHarom), 7.28–
7.43 (5 H, Ph) ppm. 13C NMR (75 MHz, CDCl3): δ = 18.4/18.8
(CCH3), 29.4/29.6 (CCH3), 33.2/37.5 (NCH3), 57.0/60.6 (NCH),
59.0/60.2 (CHCH2O), 57.3/62.5 (CHCN), 73.4/74.5 (CHPh), 98.9/
(Ar-CH), 127.6 (Ar-Cq), 127.7, 127.8, 127.9 (Ar-CH), 131.6, 138.9,
147.6, 147.9, 148.1, 151.7 (Ar-C ), 195.9 (CO) ppm IR (KBr): ν =
˜
q
3774 (w), 3450 (m), 3070 (w), 2987 (m), 2899 (m), 2813 (w), 2611
(w), 2370 (w), 2345 (w), 2216 (w), 2047 (w), 1676 (s), 1609 (m),
1489 (s), 1442 (s), 1380 (m), 1298 (m), 1248 (s), 1202 (m), 1169 (w),
1100 (m), 1037 (s), 935 (m), 895 (w), 854 (w), 813 (m), 746 (m),
99.2 (CCH3), 101.0/101.1 (OCH2O), 107.2/107.4, 107.5/107.6 (Ar- 701 (m), 669 (w), 642 (w), 574 (w), 533 (w) cm–1. MS (EI): m/z (%)
CH), 117.4/117.7 (CN), 120.3/120.4, 125.3/125.5, 126.9/127.0,
127.7/128.0 (Ar-CH), 128.0/128.6, 139.89/139.93, 147.2/147.4,
= 543 (3) [M– HCN]+·, 406 (6), 395 (13), 394 (34), 355 (11), 354
(45), 350 (10), 336 (7), 322 (8), 243 (5), 232 (7), 231 (21), 230 (100).
MS (CI, methane): m/z (%) = 570 (0.6) [M]+·, 546 (6), 545 (32), 544
(100) [M – CN]+, 543 (28), 542 (11), 487 (7), 486 (27), 395 (9), 394
147.5/147.7 (Ar-C ) ppm. IR (KBr): ν = 3464 (w), 3078 (w), 3031
˜
q
(w), 2993 (s), 2973 (m), 2937 (s), 2863 (s), 2794 (m), 2703 (w), 2670
(w), 2376 (w), 2343 (w), 2228 (w), 2043 (w), 1956 (w), 1842 (w), (20), 355 (9). C33H34N2O7 (570.24): calcd. C 69.46, H 6.01, N 4.91;
1810 (w), 1725 (w), 1607 (w), 1485 (s), 1439 (s), 1378 (s), 1316 (w), found C 69.38, H 6.04, N 4.58.
1263 (s), 1236 (s), 1202 (s), 1152 (m), 1123 (m), 1086 (s), 1041 (s),
997 (m), 957 (m), 936 (s), 894 (w), 858 (m), 829 (m), 809 (w), 782
(2R,3R)-2,5-Bis(benzo[d][1,3]dioxol-6-yl)-2-{methyl[(4S,5S)-2,2-
dimethyl-4-phenyl-1,3-dioxan-5-yl]amino}-3-methyl-5-oxopentane-
nitrile [(S,S,R,R)-8]: The Michael adduct (S,S,R,R)-8 was synthe-
sized by the same procedure as described for (R,R,S,S)-8 with use
(m), 733 (s), 697 (m), 657 (w), 595 (w), 556 (m), 528 (w), 466
(w) cm–1. MS (EI): m/z (%) = 354 (3) [M – CN]+, 217 (10), 216
(73), 215 (22), 185 (5), 176 (37), 175 (35), 161 (11), 160 (100), 91
of the amino nitrile (S,S,RS)-7. The product was obtained as a
(7), 77 (5). MS (CI, methane): m/z (%) = 380 (1.8) [M]+, 355 (19),
colourless solid, m.p. 115 °C, de Ն 96%. [α]2D4 = –43.7 (c = 1.0,
354 (100) [M – CN]+, 323 (10), 217 (10), 216 (57), 215 (5), 160 (31).
CHCl3). The spectroscopic data were identical with those of
(R,R,S,S)-8.
C
22H24N2O4 (380.44): calcd. C 69.46, H 6.36, N 7.36; found C
69.93, H 6.31, N 7.44.
(2S,3S,4S)-2,5-Bis(benzo[d][1,3]dioxol-6-yl)-2-{methyl[(4R,5R)-2,2-
dimethyl-4-phenyl-1,3-dioxan-5-yl]amino}-3,4-dimethyl-5-oxo-
pentanenitrile [(R,R,S,S,S)-9]: Potassium tert-butoxide (0.51 g,
4.53 mmol) was placed in a dry Schlenk flask and carefully heated
under vacuum to avoid sublimation. After cooling to room tem-
perature and addition of abs. THF (4.5 mL) and diisopropylamine
(0.63 mL, 4.53 mmol) the mixture was cooled to –78 °C and nBuLi
(1.6 m, 2.83 mL, 4.53 mmol) was added dropwise. The mixture was
stirred at –78 °C for 30 min, followed by addition of the Michael
(RS)-2-(Benzo[d][1,3]dioxol-6-yl)-2-{methyl[(4S,5S)-2,2-dimethyl-4-
phenyl-1,3-dioxan-5-yl]amino}acetonitrile [(S,S,R/S)-7]: The amino
nitrile (S,S,RS)-7 was synthesized by the same procedure as de-
scribed for (R,R,SR)-6 with use of the amine (S,S)-2 (ee Ͻ 99%)
as chiral auxiliary. The product was obtained as a colourless solid,
m.p. 114 °C, de = 63%. [α]2D6 = +105.0 (c = 1.1, CHCl3). The spec-
troscopic data (1H, 13C NMR, MS) were identical with those given
for (R,R,SR)-7.
(2S,3S)-2,5-Bis(benzo[d][1,3]dioxol-6-yl)-2-{methyl[(4R,5R)-2,2- adduct (R,R,S,S)-8 (2.35 g, 4.53 mmol) in THF (4.5 mL). After 4 h
dimethyl-4-phenyl-1,3-dioxan-5-yl]amino}-3-methyl-5-oxopentane- at –78 °C the reaction mixture was cooled to –100 °C and methyl
nitrile [(R,R,S,S)-8]: Diisopropylamine (1.77 mL, 12.59 mmol) was iodide (0.51 mL, 8.24 mmol) was added. The reaction mixture was
placed in a dry Schlenk flask, and abs. THF (10 mL per mmol
diisopropylamine) was added. The reaction mixture was cooled to
–78 °C and nBuLi (1.6 m, 7.88 mL, 12.61 mmol) was added drop-
wise. The mixture was stirred at 0 °C for 30 min and cooled to
–78 °C, and the amino nitrile (R,R,SR)-7 (4.0 g, 10.51 mmol) was
then added. After 1.5 h at –78 °C the reaction mixture was cooled
to –100 °C, followed by addition of the Michael acceptor (E)-5
(2.0 g, 10.51 mmol) in THF (1 mL per mmol) by syringe pump.
The reaction mixture was stirred overnight and allowed to warm
up to –10 °C. After quenching by addition of sat. NH4Cl solution
with vigorous stirring, H2O was added and the organic phase was
separated. The aqueous phase was extracted with Et2O and the
combined organic layers were washed with brine and dried with
MgSO4, and the solvents were evaporated in vacuo. The crude pro-
duct was purified by flash chromatography (silica gel, pentane/di-
ethyl ether, 1:1 with 3 % triethylamine) to give amino nitrile
stirred overnight, allowed to warm to –10 °C, and was then
quenched by addition of sat. NH4Cl solution and H2O. The aque-
ous phase was extracted with Et2O and the combined organic layers
were washed with brine, dried with MgSO4 and evaporated under
reduced pressure. Purification of the residue by flash chromatog-
raphy (silica gel, pentane/diethyl ether, 1:1 with 3% triethylamine)
afforded (R,R,S,S,S)-9 (2.19 g, 90 %), m.p. 120 °C, de = 96 %.
1
[α]2D6 = +85.2 (c = 1.0, CHCl3). H NMR (300 MHz, CDCl3): δ =
0.20 (d, J = 6.9 Hz, 3 H, COCHCH3), 0.60 (d, J = 6.9 Hz, 3 H,
CHCH3), 1.44 (s, 3 H, CCH3), 1.50 (s, 3 H, CCH3), 2.75–2.85 (m,
2 H, NCH, CHCH3), 2.97 (s, 3 H, NCH3), 3.33 (qd, 1 H, J = 6.9,
2.5 Hz, COCHCH3), 3.96 (dd, J = 13.1, 4.5 Hz, 1 H, OCHHCH),
4.73 (dd, J = 13.1, 2.2 Hz, 1 H, OCHHCH), 4.97 (d, J = 4.2 Hz, 1
H, PhCH), 5.96–6.02 (m, 1 H, CHarom) 6.03 (s, 4 H, 2×OCH2O),
6.64 (d(br), J = 7.1 Hz, 1 H, CHarom), 6.85 (d, J = 8.2 Hz, 1 H,
CHarom), 7.25–7.46 (m, 7 H, CHarom), 7.58 (dd, J = 8.2, 1.7 Hz, 1
H, CHarom) ppm. 13C NMR (75 MHz, CDCl3): δ = 8.0 (CHCH3),
12.3 (COCHCH3), 19.4 (CCH3), 28.7 (CCH3), 35.1 (NCH3), 39.8
(R,R,S,S)-8 (5.00 g, 83% yield), m.p. 115 °C. de Ն 96%. [α]2D6
=
+49.7 (c = 1.0, CHCl3). 1H NMR (300 MHz, CDCl3): δ = 0.57 (d,
J = 6.4 Hz, 3 H, CHCH3), 1.45 (s, 3 H, CCH3), 1.52 (s, 3 H, CCH3), (CHCH3), 40.5 (COCHCH3), 54.2 (NCH), 58.6 (OCH2CH), 73.2
1.83 (dd, J = 16.1, 10.9 Hz, 1 H, COCHH), 2.77 (m, 1 H, NCH), (NCC), 76.0 (PhCH) 99.4 (OCO), 101.5 (OCH2O), 101.8
2.83 (m, 1 H, COCHH), 2.92–3.01 (m, 1H, CHCH3), 3.05 (s, 3 H,
NCH3), 3.99 (dd, J = 13.2, 4.2 Hz, 1 H, OCHHCH), 4.66 (dd, J =
13.2, 2.2 Hz, 1 H, OCHHCH), 5.00 (d, J = 4.2 Hz, 1 H, PhCH),
(OCH2O), 107.8, 107.9, 108.5, 109.0 (Ar-CH), 121.6 (CN), 122.0,
124.7, 127.7, 127.9 (Ar-CH), 130.5, 138.9, 147.6, 148.1, 148.3, 151.8
(Ar-Cq), 201.1 (CO) ppm, MS (EI): m/z (%) = 558 (1.2) [M – CN]+,
5.96–6.02 (m, 1 H, CHarom), 6.00 (s, 4 H, OCH2O), 6.65 (d(br), J 436 (9), 420 (12), 409 (26), 408 (100), 379 (15), 368 (14), 365 (18),
= 7.7 Hz, 1 H, CHarom), 6.77 (d, J = 8.2 Hz, 1 H, Ar-CH), 7.25– 364 (89), 338 (6), 337 (5), 336 (9), 245 (6), 244 (45), 243 (51), 218
7.45 (m, 7 H, CHarom) ppm. 13C NMR (75 MHz, CDCl3): δ = 12.8 (5), 216 (18), 215 (25), 214 (5), 205 (21), 187 (8) ppm. IR (KBr):
Eur. J. Org. Chem. 2005, 1984–1990
© 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
1989